Mohammad Bsharat

1.1k total citations · 1 hit paper
10 papers, 803 citations indexed

About

Mohammad Bsharat is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Hepatology. According to data from OpenAlex, Mohammad Bsharat has authored 10 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cognitive Neuroscience, 5 papers in Experimental and Cognitive Psychology and 4 papers in Hepatology. Recurrent topics in Mohammad Bsharat's work include Sleep and Wakefulness Research (5 papers), Sleep and related disorders (5 papers) and Hepatitis C virus research (4 papers). Mohammad Bsharat is often cited by papers focused on Sleep and Wakefulness Research (5 papers), Sleep and related disorders (5 papers) and Hepatitis C virus research (4 papers). Mohammad Bsharat collaborates with scholars based in United States, Germany and Japan. Mohammad Bsharat's co-authors include Nathalie Adda, Shelley George, Nezam H. Afdhal, Ira M. Jacobson, Norah A. Terrault, Stefan Zeuzem, E. Jenny Heathcote, Michael P. Manns, Hendrik W. Reesink and Adrian M. Di Bisceglie and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Journal of Hepatology.

In The Last Decade

Mohammad Bsharat

10 papers receiving 784 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Telaprevir for Previously Treated Chronic HCV Infection

2010 529 citations John G. McHutchison, Michael P. Manns et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammad Bsharat United States	6	705	610	206	66	62	10	803
J. Sorbel United States	16	815 1.2×	844 1.4×	185 0.9×	26 0.4×	9 0.1×	50	1.1k
M. Raptopoulou Greece	11	219 0.3×	246 0.4×	41 0.2×	31 0.5×	1 0.0×	22	327
Elmar Jäckel Germany	11	286 0.4×	284 0.5×	53 0.3×	4 0.1×	18 0.3×	20	483
Małgorzata Zalewska Poland	10	127 0.2×	150 0.2×	54 0.3×	3 0.0×	24 0.4×	42	294
Mauro Viganò Italy	9	288 0.4×	336 0.6×	9 0.0×	15 0.2×	6 0.1×	23	414
John McHutchinson United States	8	313 0.4×	239 0.4×	19 0.1×	1 0.0×	55 0.9×	11	428
Shimaa Afify Egypt	10	147 0.2×	170 0.3×	75 0.4×	2 0.0×	11 0.2×	33	314
Jasmina Medjedovic United States	7	164 0.2×	197 0.3×	26 0.1×	17 0.3×	8 0.1×	8	346
Hana Guberina Germany	13	48 0.1×	70 0.1×	46 0.2×	15 0.2×	8 0.1×	20	273

Countries citing papers authored by Mohammad Bsharat

Since Specialization

Citations

This map shows the geographic impact of Mohammad Bsharat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Bsharat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Bsharat more than expected).

Fields of papers citing papers by Mohammad Bsharat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Bsharat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Bsharat. The network helps show where Mohammad Bsharat may publish in the future.

Co-authorship network of co-authors of Mohammad Bsharat

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Bsharat. A scholar is included among the top collaborators of Mohammad Bsharat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Bsharat. Mohammad Bsharat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Moline, Margaret, Stephen Thein, Mohammad Bsharat, et al.. (2021). Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial. The Journal of Prevention of Alzheimer s Disease. 8(1). 7–18. 31 indexed citations

2.

Cheng, Jocelyn Y., Margaret Moline, Gary Zammit, et al.. (2021). Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Clinical Drug Investigation. 41(5). 449–457. 5 indexed citations

3.

Cheng, Jocelyn Y., Gleb Filippov, Margaret Moline, et al.. (2020). Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study. Journal of Sleep Research. 29(4). e13021–e13021. 31 indexed citations

4.

Thein, Stephen, et al.. (2019). F1‐06‐04: RESPONSE TO TREATMENT WITH LEMBOREXANT: SUBJECTS WITH IRREGULAR SLEEP‐WAKE RHYTHM DISORDER AND ALZHEIMER'S DISEASE DEMENTIA. Alzheimer s & Dementia. 15(7S_Part_3). 4 indexed citations

5.

Cheng, Jocelyn Y., Margaret Moline, Gleb Filippov, et al.. (2019). 0429 Respiratory Safety of Lemborexant in Adult and Elderly Subjects with Mild Obstructive Sleep Apnea. SLEEP. 42(Supplement_1). A173–A174. 2 indexed citations

6.

Chilvers, Mark, Simon Tian, Gautham Marigowda, et al.. (2017). 52 An open-label extension (EXT) study of lumacaftor/ivacaftor (LUM/IVA) therapy in patients (pts) aged 6–11 years (yrs) with cystic fibrosis (CF) homozygous for F508del-CFTR. Journal of Cystic Fibrosis. 16. S77–S77. 5 indexed citations

7.

Sulkowski, Mark, Kenneth E. Sherman, Douglas T. Dieterich, et al.. (2013). Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV. Annals of Internal Medicine. 159(2). 86–96. 156 indexed citations

8.

Dieterich, Douglas T., Vincent Soriano, Kenneth E. Sherman, et al.. (2012). Telaprevir in combination with peginterferon Alfa-2a/ribavirin in HCV/HIV co-infected patients: SVR12 interim analysis. 3. 16 indexed citations

9.

McHutchison, John G., Michael P. Manns, Andrew J. Muir, et al.. (2010). Telaprevir for Previously Treated Chronic HCV Infection. New England Journal of Medicine. 362(14). 1292–1303. 529 indexed citations breakdown →

10.

Manns, M.P., Andrew J. Muir, Nathalie Adda, et al.. (2009). 1044 TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON- ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY. Journal of Hepatology. 50. S379–S379. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact